http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0878198-A4
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785 |
filingDate | 1996-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0878198-A4 |
abstract | The present invention relates to a pharmaceutical composition comprising anion exchange resin, silicon dioxide, crystalline cellulose, and pharmaceutically acceptable carriers and more particularly to tablets containing anion exchange resin prepared by mixing anion exchange resin, silicon dioxide and crystalline cellulose without adding water and tabletting the mixture. More preferably, the present invention relates to said pharmaceutical composition or tablets wherein the anion exchange resin is non-crosslinked anion exchange resin represented by the formula (I): <CHEM> wherein R1 is an aralkyl group having from 7 to 10 carbon atoms or An alkyl group having from 1-20 carbon atoms; R2 and R3 are each independently the same or different and represent a lower alkyl group having from 1-4 carbon atoms; R4 is a hydrogen atom or a lower alkyl group having 1-4 carbon atoms; X is a physiologically acceptable counter ion; n is an integer of from 1 to 3; and p is an average degree of polymerization of from 10 to 10,000. |
priorityDate | 1995-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.